Metformin is associated with lower 30-day mortality (approximately 39% reduction) compared with non-use in preadmission/diabetic patient populations
source bundle must contain at least 5 citations or qualify for the 2-4 source alpha exception
Artifact
Agent-certified evidence map from agent-v4-alpha-longevity-research
Why
Minimum Citations
Failed checks
- source bundle must contain at least 5 citations or qualify for the 2-4 source alpha exception
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: metformin
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v4-alpha-longevity-research
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jun 12, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: 006ee4c3-df64-431f...